chr6-10770188-A-G

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001242957.3(MAK):ā€‹c.1715T>Cā€‹(p.Ile572Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00349 in 1,614,144 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0047 ( 2 hom., cov: 32)
Exomes š‘“: 0.0034 ( 24 hom. )

Consequence

MAK
NM_001242957.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 1.05
Variant links:
Genes affected
MAK (HGNC:6816): (male germ cell associated kinase) The product of this gene is a serine/threonine protein kinase related to kinases involved in cell cycle regulation. Studies of the mouse and rat homologs have localized the kinase to the chromosomes during meiosis in spermatogenesis, specifically to the synaptonemal complex that exists while homologous chromosomes are paired. Mutations in this gene have been associated with ciliary defects resulting in retinitis pigmentosa 62. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
TMEM14B (HGNC:21384): (transmembrane protein 14B) Enables identical protein binding activity. Involved in cerebral cortex development; neural precursor cell proliferation; and regulation of G1/S transition of mitotic cell cycle. Predicted to be integral component of membrane. Predicted to be active in mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009576261).
BP6
Variant 6-10770188-A-G is Benign according to our data. Variant chr6-10770188-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 194362.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=1, Benign=2}. Variant chr6-10770188-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00471 (717/152310) while in subpopulation AFR AF= 0.00825 (343/41570). AF 95% confidence interval is 0.00753. There are 2 homozygotes in gnomad4. There are 356 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MAKNM_001242957.3 linkuse as main transcriptc.1715T>C p.Ile572Thr missense_variant 14/15 ENST00000354489.7 NP_001229886.1 P20794-2F8VBW7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MAKENST00000354489.7 linkuse as main transcriptc.1715T>C p.Ile572Thr missense_variant 14/155 NM_001242957.3 ENSP00000346484.3 P20794-2
ENSG00000272162ENST00000480294.1 linkuse as main transcriptn.100+20490A>G intron_variant 2 ENSP00000417929.1 F8WBI7

Frequencies

GnomAD3 genomes
AF:
0.00471
AC:
717
AN:
152192
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00828
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00557
Gnomad ASJ
AF:
0.0138
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.00312
Gnomad OTH
AF:
0.00812
GnomAD3 exomes
AF:
0.00375
AC:
943
AN:
251294
Hom.:
7
AF XY:
0.00373
AC XY:
507
AN XY:
135812
show subpopulations
Gnomad AFR exome
AF:
0.00886
Gnomad AMR exome
AF:
0.00457
Gnomad ASJ exome
AF:
0.0151
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00150
Gnomad FIN exome
AF:
0.000370
Gnomad NFE exome
AF:
0.00342
Gnomad OTH exome
AF:
0.00751
GnomAD4 exome
AF:
0.00337
AC:
4921
AN:
1461834
Hom.:
24
Cov.:
31
AF XY:
0.00346
AC XY:
2519
AN XY:
727222
show subpopulations
Gnomad4 AFR exome
AF:
0.00848
Gnomad4 AMR exome
AF:
0.00418
Gnomad4 ASJ exome
AF:
0.0146
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00121
Gnomad4 FIN exome
AF:
0.000150
Gnomad4 NFE exome
AF:
0.00321
Gnomad4 OTH exome
AF:
0.00550
GnomAD4 genome
AF:
0.00471
AC:
717
AN:
152310
Hom.:
2
Cov.:
32
AF XY:
0.00478
AC XY:
356
AN XY:
74488
show subpopulations
Gnomad4 AFR
AF:
0.00825
Gnomad4 AMR
AF:
0.00556
Gnomad4 ASJ
AF:
0.0138
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000621
Gnomad4 FIN
AF:
0.0000941
Gnomad4 NFE
AF:
0.00312
Gnomad4 OTH
AF:
0.00803
Alfa
AF:
0.00410
Hom.:
7
Bravo
AF:
0.00493
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.00976
AC:
43
ESP6500EA
AF:
0.00314
AC:
27
ExAC
AF:
0.00335
AC:
407
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00485
EpiControl
AF:
0.00522

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2018- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 18, 2015- -
Likely benign, criteria provided, single submitterclinical testingInstitute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's HospitalMay 08, 2017BS1,BP4; This alteration has an allele frequency that is greater than expected for the associated disease, and is predicted to be tolerated by multiple functional prediction tools. -
Retinitis pigmentosa 62 Benign:2
Likely benign, criteria provided, single submitterclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical CenterJun 28, 2017- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Retinitis Pigmentosa, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
15
DANN
Benign
0.85
DEOGEN2
Benign
0.056
T;T;.
Eigen
Benign
-0.70
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.38
N
LIST_S2
Benign
0.65
.;T;T
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.0096
T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.55
N;N;.
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
-1.7
N;.;.
REVEL
Benign
0.13
Sift
Benign
0.040
D;.;.
Sift4G
Uncertain
0.059
T;T;T
Polyphen
0.011
B;B;.
Vest4
0.19
MVP
0.68
MPC
0.21
ClinPred
0.0037
T
GERP RS
2.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.051
gMVP
0.52

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs79544660; hg19: chr6-10770421; COSMIC: COSV99046097; API